Ankasa Regenerative Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2014. They cover business area such as developer, protein-base stem cell activation therapy, tissue repair, regeneration, patient-derive stem cell, reconstructive surgery, safe and effective enhancement, bone formation, clinician, revision surgery, their attendant complication.
2014
( 10 years old in 2024 )
Developer
-
11099 North Torrey Pines Road
Suite 290, La Jolla
San Diego, CA 92037
United States
Private
developerprotein-base stem cell activation therapytissue repairregenerationpatient-derive stem cellreconstructive surgerysafe and effective enhancementbone formationclinicianrevision surgerytheir attendant complication
* We use standard office opening hours in near Ankasa Regenerative Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ankasa Regenerative Therapeutics is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), Ankasa Regenerative Therapeutics business is focusing on Developer.
Ankasa Regenerative Therapeutics headquarter office and corporate office address is located in 11099 North Torrey Pines Road Suite 290, La Jolla San Diego, CA 92037 United States.
Ankasa Regenerative Therapeutics was founded in United States.
In 2024, Ankasa Regenerative Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ankasa Regenerative Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
